ClinicalTrials.Veeva

Menu

Levels of Visfatin/NAMPT in Human Milk (VISFAMILK)

P

Paolo Manzoni Study Group

Status

Enrolling

Conditions

Birth Weight
Visfatin Levels in Maternal Milk Samples

Treatments

Other: observational study

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Visfatin, released in maternal milk at different concentrations related to the maternal conditions, could act as a biomarker with a prognostic/predictive value to determine different newborn clinical conditions, particularly the weight loss of the neonate.

Full description

The aim of the study is to analyse a retrospective cohort of well characterized mothers in their post-partum period, and to measure Visfatin levels through collection of maternal milk samples. They will be collected in three different moments after the birth (48 hours, 7 days and 30 days) and Visfatin levels will be analysed through an ELISA kit Adipogen. In parallel, the levels of Visfatin will be evaluated in the maternal plasma/serum collected after 1-2 days postpartum.

Lastly, correlations between Visfatin levels and biological/clinical features of mothers and newborns will be explored.

Enrollment

30 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Healthy male and female infants born after 37 weeks' gestation who do not have conditions related to congenital abnormalities
  • Maternal hospitalization
  • Acquisition of the informed consent form signed by the patient

Exclusion criteria

  • Refusal of the patient to participate in the study
  • Presence of hypogalactia or agalactia in the patient

Trial contacts and locations

1

Loading...

Central trial contact

Paolo Manzoni, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems